This statement of work aims to present a study to assess the atrial electrophysiological characteristics of a porcine model of hypertrophic cardiomyopathy, and to evaluate the cardiovascular effects of the Sponsor’s novel myosin inhibitor (MYK-461)
|Effective start/end date||4/1/21 → 3/31/22|
- MyoKardia, Inc. (Agmt 04/01/21)
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.